Synonn Lifesciences Limited, a struck off public limited company, was established on 12 December 2008 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51397DL2008PLC185780. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.77 M and a paid-up capital of ₹2.77 M.
It upholds a compliant status. Employing 10 professional, Its leadership includes Krishnendu Kumar Dey (Director), Rahul Rangrao Patil (Director), Rajendra Kishorilal Goyal (Director). Past directors included Sanjay Kumar Chawala, Dinesh Kumar Talwar, Rajendra Kishorilal Goyal. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 305, Jaina Tower Ii District Centre, Janakpuri, New Delhi, Delhi, 110058.
U51397DL2008PLC185780
185780
12 December 2008
₹2.77 M
₹2.77 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Synonn Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnendu Kumar Dey | Director | 12 Dec 2008 | Current |
| Rahul Rangrao Patil | Director | 12 Dec 2008 | Current |
| Rajendra Kishorilal Goyal | Director | 02 Sep 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2009 | Past |
| Pramod Abcsdd | Director | 02 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synonn Lifesciences Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 3.61% increase. The company also saw a substantial fall in profitability, with a 54.74% decrease in profit. The company's net worth moved up by a moderate rise of 0.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Synonn Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Synonn Lifesciences has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Synonn Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synonn Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Synonn Lifesciences Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.
Progress on Synonn Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was documented.
The activity Rajendra Kishorilal Goyal was appointed as a Director was appointed as a Director on 02 Sep 2013 & has been associated with this company since 12 years 3 months . was completed.
Progress on Krishnendu Kumar Dey was appointed as a Director was appointed as a Director on 12 Dec 2008 & has been associated with this company since 17 years 5 days . was documented.
The activity Rahul Rangrao Patil was appointed as a Director was appointed as a Director on 12 Dec 2008 & has been associated with this company since 17 years 5 days . was completed.
Synonn Lifesciences Limited was registered on 12 Dec 2008 with Roc Delhi & aged 17 years 5 days as per MCA records. was recorded as a recent event.
The CIN of Synonn Lifesciences Limited is U51397DL2008PLC185780.
Synonn Lifesciences Limited is headquartered at 305, Jaina Tower Ii District Centre, Janakpuri, New Delhi, Delhi, 110058.
Synonn Lifesciences Limited was incorporated on 12 December 2008.
The current directors of Synonn Lifesciences Limited are
The primary industry of Synonn Lifesciences Limited is Manufacturing.
Synonn Lifesciences Limited is unlisted.
The authorized capital of Synonn Lifesciences Limited is ₹2.77 M, and the paid-up capital is ₹2.77 M.
The compliance status of Synonn Lifesciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX